Exelixis faces proxy battle with investor Farallon Capital (update) Posted on April 6, 2023 By Charlielikes Stock Market
Exelixis has mixed ruling in Cabometyx patent trial, wins on 2026, loses on 2030 (update) Posted on January 20, 2023 By Charlielikes Stock Market
Exelixis makes two scientific executive changes Posted on December 15, 2022 By Charlielikes Stock Market